Aurobindo Pharma added 1.44% to Rs 1241.30 after the company’s wholly owned subsidiary Aurobindo Pharma USA Inc entered into a collaboration and license agreement with a global pharma major.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
